- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-15-15-15-15-mer
- Ligands
- 15 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3(Non-covalent)
- 15 x J77: (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE(Non-covalent)
J77.2: 13 residues within 4Å:- Chain A: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain C: A.24
15 PLIP interactions:14 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:I.108, A:Y.110, A:Y.110, A:F.132, A:Y.157, A:Y.157, A:P.179, A:V.194, A:V.194, A:V.197, A:F.236, A:F.236, A:F.236, C:A.24
- pi-Stacking: A:Y.203
J77.5: 13 residues within 4Å:- Chain E: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain G: A.24
15 PLIP interactions:14 interactions with chain E, 1 interactions with chain G- Hydrophobic interactions: E:I.108, E:Y.110, E:Y.110, E:F.132, E:Y.157, E:Y.157, E:P.179, E:V.194, E:V.194, E:V.197, E:F.236, E:F.236, E:F.236, G:A.24
- pi-Stacking: E:Y.203
J77.8: 13 residues within 4Å:- Chain I: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain K: A.24
15 PLIP interactions:14 interactions with chain I, 1 interactions with chain K- Hydrophobic interactions: I:I.108, I:Y.110, I:Y.110, I:F.132, I:Y.157, I:Y.157, I:P.179, I:V.194, I:V.194, I:V.197, I:F.236, I:F.236, I:F.236, K:A.24
- pi-Stacking: I:Y.203
J77.11: 13 residues within 4Å:- Chain M: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain O: A.24
15 PLIP interactions:14 interactions with chain M, 1 interactions with chain O- Hydrophobic interactions: M:I.108, M:Y.110, M:Y.110, M:F.132, M:Y.157, M:Y.157, M:P.179, M:V.194, M:V.194, M:V.197, M:F.236, M:F.236, M:F.236, O:A.24
- pi-Stacking: M:Y.203
J77.14: 13 residues within 4Å:- Chain Q: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain S: A.24
15 PLIP interactions:14 interactions with chain Q, 1 interactions with chain S- Hydrophobic interactions: Q:I.108, Q:Y.110, Q:Y.110, Q:F.132, Q:Y.157, Q:Y.157, Q:P.179, Q:V.194, Q:V.194, Q:V.197, Q:F.236, Q:F.236, Q:F.236, S:A.24
- pi-Stacking: Q:Y.203
J77.17: 13 residues within 4Å:- Chain U: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain W: A.24
15 PLIP interactions:1 interactions with chain W, 14 interactions with chain U- Hydrophobic interactions: W:A.24, U:I.108, U:Y.110, U:Y.110, U:F.132, U:Y.157, U:Y.157, U:P.179, U:V.194, U:V.194, U:V.197, U:F.236, U:F.236, U:F.236
- pi-Stacking: U:Y.203
J77.20: 13 residues within 4Å:- Chain 0: A.24
- Chain Y: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
15 PLIP interactions:14 interactions with chain Y, 1 interactions with chain 0- Hydrophobic interactions: Y:I.108, Y:Y.110, Y:Y.110, Y:F.132, Y:Y.157, Y:Y.157, Y:P.179, Y:V.194, Y:V.194, Y:V.197, Y:F.236, Y:F.236, Y:F.236, 0:A.24
- pi-Stacking: Y:Y.203
J77.23: 13 residues within 4Å:- Chain 2: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain 4: A.24
15 PLIP interactions:1 interactions with chain 4, 14 interactions with chain 2- Hydrophobic interactions: 4:A.24, 2:I.108, 2:Y.110, 2:Y.110, 2:F.132, 2:Y.157, 2:Y.157, 2:P.179, 2:V.194, 2:V.194, 2:V.197, 2:F.236, 2:F.236, 2:F.236
- pi-Stacking: 2:Y.203
J77.26: 13 residues within 4Å:- Chain 6: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain 8: A.24
15 PLIP interactions:14 interactions with chain 6, 1 interactions with chain 8- Hydrophobic interactions: 6:I.108, 6:Y.110, 6:Y.110, 6:F.132, 6:Y.157, 6:Y.157, 6:P.179, 6:V.194, 6:V.194, 6:V.197, 6:F.236, 6:F.236, 6:F.236, 8:A.24
- pi-Stacking: 6:Y.203
J77.29: 13 residues within 4Å:- Chain a: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain c: A.24
15 PLIP interactions:14 interactions with chain a, 1 interactions with chain c- Hydrophobic interactions: a:I.108, a:Y.110, a:Y.110, a:F.132, a:Y.157, a:Y.157, a:P.179, a:V.194, a:V.194, a:V.197, a:F.236, a:F.236, a:F.236, c:A.24
- pi-Stacking: a:Y.203
J77.32: 13 residues within 4Å:- Chain e: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain g: A.24
15 PLIP interactions:14 interactions with chain e, 1 interactions with chain g- Hydrophobic interactions: e:I.108, e:Y.110, e:Y.110, e:F.132, e:Y.157, e:Y.157, e:P.179, e:V.194, e:V.194, e:V.197, e:F.236, e:F.236, e:F.236, g:A.24
- pi-Stacking: e:Y.203
J77.35: 13 residues within 4Å:- Chain i: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain k: A.24
15 PLIP interactions:14 interactions with chain i, 1 interactions with chain k- Hydrophobic interactions: i:I.108, i:Y.110, i:Y.110, i:F.132, i:Y.157, i:Y.157, i:P.179, i:V.194, i:V.194, i:V.197, i:F.236, i:F.236, i:F.236, k:A.24
- pi-Stacking: i:Y.203
J77.38: 13 residues within 4Å:- Chain m: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain o: A.24
15 PLIP interactions:14 interactions with chain m, 1 interactions with chain o- Hydrophobic interactions: m:I.108, m:Y.110, m:Y.110, m:F.132, m:Y.157, m:Y.157, m:P.179, m:V.194, m:V.194, m:V.197, m:F.236, m:F.236, m:F.236, o:A.24
- pi-Stacking: m:Y.203
J77.41: 13 residues within 4Å:- Chain q: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain s: A.24
15 PLIP interactions:14 interactions with chain q, 1 interactions with chain s- Hydrophobic interactions: q:I.108, q:Y.110, q:Y.110, q:F.132, q:Y.157, q:Y.157, q:P.179, q:V.194, q:V.194, q:V.197, q:F.236, q:F.236, q:F.236, s:A.24
- pi-Stacking: q:Y.203
J77.44: 13 residues within 4Å:- Chain u: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain w: A.24
15 PLIP interactions:14 interactions with chain u, 1 interactions with chain w- Hydrophobic interactions: u:I.108, u:Y.110, u:Y.110, u:F.132, u:Y.157, u:Y.157, u:P.179, u:V.194, u:V.194, u:V.197, u:F.236, u:F.236, u:F.236, w:A.24
- pi-Stacking: u:Y.203
- 15 x MYR: MYRISTIC ACID(Covalent)
MYR.3: 10 residues within 4Å:- Chain D: G.1, A.2, Y.31
- Chain H: V.4, T.27, I.29, Y.31
- Chain O: L.2
- Ligands: MYR.6, MYR.15
2 PLIP interactions:1 interactions with chain O, 1 interactions with chain H- Hydrophobic interactions: O:L.2
- Hydrogen bonds: H:T.27
MYR.6: 10 residues within 4Å:- Chain H: G.1, A.2, Y.31
- Chain L: V.4, T.27, I.29, Y.31
- Chain S: L.2
- Ligands: MYR.3, MYR.9
1 PLIP interactions:1 interactions with chain S- Hydrophobic interactions: S:L.2
MYR.9: 10 residues within 4Å:- Chain C: L.2
- Chain L: G.1, A.2, Y.31
- Chain P: V.4, T.27, I.29, Y.31
- Ligands: MYR.6, MYR.12
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.2
MYR.12: 10 residues within 4Å:- Chain G: L.2
- Chain P: G.1, A.2, Y.31
- Chain T: V.4, T.27, I.29, Y.31
- Ligands: MYR.9, MYR.15
2 PLIP interactions:1 interactions with chain G, 1 interactions with chain T- Hydrophobic interactions: G:L.2
- Hydrogen bonds: T:T.27
MYR.15: 10 residues within 4Å:- Chain D: V.4, T.27, I.29, Y.31
- Chain K: L.2
- Chain T: G.1, A.2, Y.31
- Ligands: MYR.3, MYR.12
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain K- Hydrogen bonds: D:T.27
- Hydrophobic interactions: K:L.2
MYR.18: 10 residues within 4Å:- Chain 1: V.4, T.27, I.29, Y.31
- Chain 8: L.2
- Chain X: G.1, A.2, Y.31
- Ligands: MYR.21, MYR.30
2 PLIP interactions:1 interactions with chain 1, 1 interactions with chain 8- Hydrogen bonds: 1:T.27
- Hydrophobic interactions: 8:L.2
MYR.21: 10 residues within 4Å:- Chain 1: G.1, A.2, Y.31
- Chain 5: V.4, T.27, I.29, Y.31
- Ligands: MYR.18, MYR.24
- Chain c: L.2
2 PLIP interactions:1 interactions with chain 5, 1 interactions with chain c- Hydrogen bonds: 5:T.27
- Hydrophobic interactions: c:L.2
MYR.24: 10 residues within 4Å:- Chain 5: G.1, A.2, Y.31
- Chain 9: V.4, T.27, I.29, Y.31
- Chain W: L.2
- Ligands: MYR.21, MYR.27
2 PLIP interactions:1 interactions with chain 9, 1 interactions with chain W- Hydrogen bonds: 9:T.27
- Hydrophobic interactions: W:L.2
MYR.27: 10 residues within 4Å:- Chain 0: L.2
- Chain 9: G.1, A.2, Y.31
- Ligands: MYR.24, MYR.30
- Chain d: V.4, T.27, I.29, Y.31
1 PLIP interactions:1 interactions with chain 0- Hydrophobic interactions: 0:L.2
MYR.30: 10 residues within 4Å:- Chain 4: L.2
- Chain X: V.4, T.27, I.29, Y.31
- Ligands: MYR.18, MYR.27
- Chain d: G.1, A.2, Y.31
1 PLIP interactions:1 interactions with chain 4- Hydrophobic interactions: 4:L.2
MYR.33: 10 residues within 4Å:- Ligands: MYR.36, MYR.45
- Chain h: G.1, A.2, Y.31
- Chain l: V.4, T.27, I.29, Y.31
- Chain s: L.2
2 PLIP interactions:1 interactions with chain s, 1 interactions with chain l- Hydrophobic interactions: s:L.2
- Hydrogen bonds: l:T.27
MYR.36: 10 residues within 4Å:- Ligands: MYR.33, MYR.39
- Chain l: G.1, A.2, Y.31
- Chain p: V.4, T.27, I.29, Y.31
- Chain w: L.2
2 PLIP interactions:1 interactions with chain w, 1 interactions with chain p- Hydrophobic interactions: w:L.2
- Hydrogen bonds: p:T.27
MYR.39: 10 residues within 4Å:- Ligands: MYR.36, MYR.42
- Chain g: L.2
- Chain p: G.1, A.2, Y.31
- Chain t: V.4, T.27, I.29, Y.31
1 PLIP interactions:1 interactions with chain g- Hydrophobic interactions: g:L.2
MYR.42: 10 residues within 4Å:- Ligands: MYR.39, MYR.45
- Chain k: L.2
- Chain t: G.1, A.2, Y.31
- Chain x: V.4, T.27, I.29, Y.31
1 PLIP interactions:1 interactions with chain k- Hydrophobic interactions: k:L.2
MYR.45: 10 residues within 4Å:- Ligands: MYR.33, MYR.42
- Chain h: V.4, T.27, I.29, Y.31
- Chain o: L.2
- Chain x: G.1, A.2, Y.31
2 PLIP interactions:1 interactions with chain h, 1 interactions with chain o- Hydrogen bonds: h:T.27
- Hydrophobic interactions: o:L.2
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grant, R.A. et al., Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr.Biol. (1994)
- Release Date
- 1996-07-11
- Peptides
- POLIOVIRUS TYPE 3: AEIMQUY26aeimqu
POLIOVIRUS TYPE 3: BFJNRVZ37bfjnrv
POLIOVIRUS TYPE 3: CGKOSW048cgkosw
POLIOVIRUS TYPE 3: DHLPTX159dhlptx - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1U
1Y
12
16
1a
1e
1i
1m
1q
1u
1B
2F
2J
2N
2R
2V
2Z
23
27
2b
2f
2j
2n
2r
2v
2C
3G
3K
3O
3S
3W
30
34
38
3c
3g
3k
3o
3s
3w
3D
4H
4L
4P
4T
4X
41
45
49
4d
4h
4l
4p
4t
4x
4
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-15-15-15-15-mer
- Ligands
- 15 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3(Non-covalent)
- 15 x J77: (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE(Non-covalent)
- 15 x MYR: MYRISTIC ACID(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grant, R.A. et al., Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr.Biol. (1994)
- Release Date
- 1996-07-11
- Peptides
- POLIOVIRUS TYPE 3: AEIMQUY26aeimqu
POLIOVIRUS TYPE 3: BFJNRVZ37bfjnrv
POLIOVIRUS TYPE 3: CGKOSW048cgkosw
POLIOVIRUS TYPE 3: DHLPTX159dhlptx - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1U
1Y
12
16
1a
1e
1i
1m
1q
1u
1B
2F
2J
2N
2R
2V
2Z
23
27
2b
2f
2j
2n
2r
2v
2C
3G
3K
3O
3S
3W
30
34
38
3c
3g
3k
3o
3s
3w
3D
4H
4L
4P
4T
4X
41
45
49
4d
4h
4l
4p
4t
4x
4